Tayside Clinical Trials Unit

Medicine & Life Sciences

1. Randomized Controlled Trials 100%
2. Hepacivirus 41%
3. Methylphenidate 39%
4. Hepatitis C 38%
5. Scotland 38%
6. Placebos 36%
7. Physical Functional Performance 33%
8. Perindopril 29%
9. Sarcopenia 28%
10. Early Detection of Cancer 26%
11. Lung Neoplasms 25%
12. Antiviral Agents 24%
13. Opiate Substitution Treatment 23%
14. Myotonic Dystrophy 23%
15. Attention Deficit Disorder with Hyperactivity 23%
16. Therapeutics 22%
17. Accidental Falls 20%
18. Quality of Life 20%
19. Pharmacies 20%
20. Feasibility Studies 19%
21. Cost-Benefit Analysis 18%
22. Text Messaging 18%
23. Pharmaceutical Preparations 17%
24. Chronic Renal Insufficiency 17%
25. Stroke Rehabilitation 17%
26. Sodium Bicarbonate 17%
27. Angiotensin-Converting Enzyme Inhibitors 17%
28. Confidence Intervals 16%
29. Leucine 16%
30. Neurogenic Bowel 15%
31. Motivation 14%
32. Weights and Measures 14%
33. Breast Neoplasms 14%
34. Health Care Outcome Assessment 14%
35. Biomarkers 14%
36. Pharmacists 14%
37. Bicarbonates 14%
38. Blood Pressure 13%
39. Image-Guided Biopsy 13%
40. Cognitive Behavioral Therapy 13%
41. Child 13%
42. Cohort Studies 13%
43. Long Term Adverse Effects 12%
44. Cardiovascular Diseases 12%
45. Autoantibodies 12%
46. Primary Health Care 12%
47. Muscles 12%
48. Exercise 12%
49. Allopurinol 12%
50. Health 12%
51. Atherosclerotic Plaques 12%
52. Lung 11%
53. Pharmacy 11%
54. Sustained Virologic Response 11%
55. Weight Loss 11%
56. Costs and Cost Analysis 11%
57. Population 11%
58. Left Ventricular Hypertrophy 11%
59. Vascular Stiffness 11%
60. Acidosis 11%
61. Massage 11%
62. Prostatic Neoplasms 11%
63. Art 10%
64. Chronic Obstructive Pulmonary Disease 10%
65. Multiparametric Magnetic Resonance Imaging 10%
66. Interviews 9%
67. Blood Vessels 9%
68. Vitamin D 9%
69. Hypertension 9%
70. Control Groups 9%
71. Magnetic Resonance Imaging 9%
72. Colorectal Neoplasms 9%
73. Elasticity Imaging Techniques 9%
74. Smoking 9%
75. N-(2-acetamido)-2-aminoethanesulfonic acid 9%
76. National Health Programs 9%
77. 4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide 9%
78. Incidence 9%
79. Vitamin K 2 8%
80. Psychology 8%
81. Directly Observed Therapy 8%
82. Life Style 8%
83. Intention 8%
84. Prisons 8%
85. Hematologic Tests 8%
86. Asthma 8%
87. Quality-Adjusted Life Years 8%
88. Cholecalciferol 8%
89. Mannose-Binding Protein Deficiency 7%
90. Fatigue 7%
91. Desmosine 7%
92. 25-hydroxyvitamin D 7%
93. Point-of-Care Systems 7%
94. Glomerular Filtration Rate 7%
95. Breast 7%
96. Random Allocation 7%
97. Dipeptidyl-Peptidases and Tripeptidyl-Peptidases 7%
98. Phosphocreatine 7%
99. Exercise Therapy 7%
100. Multiple Sclerosis 7%
101. Podiatry 7%
102. Controlled Before-After Studies 7%
103. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 7%
104. Meta-Analysis 7%
105. Space Simulation 7%
106. Vitamin K 6%
107. Neoplasms 6%
108. Smoking Cessation 6%
109. Needles 6%
110. Infections 6%
111. SARS Virus 6%
112. Nurses 6%
113. Orthostatic Hypotension 6%
114. Syringes 6%
115. Electronic Nicotine Delivery Systems 6%
116. Proctitis 6%
117. Angiotensin Receptor Antagonists 6%
118. Kidney 6%
119. Volunteers 6%
120. Type 2 Diabetes Mellitus 6%
121. Interferons 6%
122. Actinic Keratosis 6%
123. Neoplasm Antigens 6%
124. Mentoring 6%
125. Ultrasonic Waves 6%
126. Clinical Trials 6%
127. Rehabilitation 5%
128. Spironolactone 5%
129. Hepatitis Viruses 5%
130. Informatics 5%
131. Opioid Analgesics 5%
132. Psychiatry 5%
133. Ankle Brachial Index 5%
134. Smokers 5%
135. Cardiac Rehabilitation 5%
136. Splints 5%
137. Education 5%
138. Pamphlets 5%
139. Biopsy 5%
140. Overweight 5%
141. Pregnancy 5%
142. Mortality 5%
143. Carotid Intima-Media Thickness 5%
144. Diet 5%
145. Lymph Nodes 5%
146. Football 5%
147. Microwaves 5%
148. Obesity 5%
149. Systematic Reviews 5%
150. Methadone 5%
151. Frailty 5%
152. Magnetic Resonance Angiography 5%
153. Tomography 5%
154. Demography 5%
155. Ribavirin 5%
156. Liver Diseases 5%
157. Telephone 5%
158. Suicide 5%
159. Magnetic Resonance Spectroscopy 5%
160. Lithium 5%